You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Pulmonology

Pediatric Asthma Patient Case Tool: Ash

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

Learning objectives

  • Learn about identifying uncontrolled asthma and type 2 inflammation based on the latest guidelines

Description

Meet Ash! Journey through his patient case, using guideline-based checklists and clinical information, to determine if he has uncontrolled severe asthma driven by type 2 inflammation.

Tags
patient casepediatricguidelinesdisease controltype 2 inflammationbiomarkers
MAT-GLB-2203664 - 3.0 - 11/2024

Related resources

GINA Asthma Decision Tree
Pulmonology
videoanimation

GINA Asthma Decision Tree

Asthma White Board Video
Pulmonology
videoanimation

Asthma White Board Video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission
Pulmonology
expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Pulmonology
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
Pulmonology
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

On-Treatment Clinical Remission in Asthma Patients Case Tool
Pulmonology
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pediatric Asthma Patient Case Tool: Ash
Pulmonology
interactivity

Pediatric Asthma Patient Case Tool: Ash

Blood Eosinophils: A Biomarker in COPD
Pulmonology
Infographic

Blood Eosinophils: A Biomarker in COPD

Adult Asthma Interactive Patient Cases
Pulmonology
interactivity

Adult Asthma Interactive Patient Cases

Clinical Manifestations Associated With Airway Remodeling in Asthma
Type 2 Inflammation
expert video

Clinical Manifestations Associated With Airway Remodeling in Asthma

Impact of Exacerbations in COPD
Type 2 Inflammation
expert video

Impact of Exacerbations in COPD

Exacerbations Lead to Worsening Lung Function
Type 2 Inflammation
expert video

Exacerbations Lead to Worsening Lung Function

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IndiaChange country/region